NCT06577467View on ClinicalTrials.gov

Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection

RecruitingOBSERVATIONAL

Enrollment

12

Participants

Timeline

Start Date

March 27, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2027

Conditions

PASC Post Acute Sequelae of COVID-19

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH